1-(oxolan-2-yl)ethan-1-one - CAS 25252-64-6
Catalog: |
BB058414 |
Product Name: |
1-(oxolan-2-yl)ethan-1-one |
CAS: |
25252-64-6 |
Synonyms: |
1-(oxolan-2-yl)ethan-1-one; 1-(oxolan-2-yl)ethanone; 1-tetrahydrofuran-2-ylethanone; 1-(tetrahydrofuran-2-yl)ethanone; 1-[(2R)-tetrahydrofuran-2-yl]ethanone; 1-(tetrahydro-2-furanyl)-ethanone; acetyltetrahydrofuran; 2-acetyltetrahydrofuran |
IUPAC Name: | 1-(oxolan-2-yl)ethanone |
Description: | 1-(oxolan-2-yl)ethan-1-one (cas# 25252-64-6) is a useful research chemical. |
Molecular Weight: | 114.14 |
Molecular Formula: | C6H10O2 |
Canonical SMILES: | CC(=O)C1CCCO1 |
InChI: | InChI=1S/C6H10O2/c1-5(7)6-3-2-4-8-6/h6H,2-4H2,1H3 |
InChI Key: | KWBQKUZVJVKXHI-UHFFFAOYSA-N |
GHS Hazard Statement: | H227 (100%): Combustible liquid [Warning Flammable liquids] |
Precautionary Statement: | P210, P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P370+P378, P403, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-212512202-U | Drying device for medical intermediate | 20200611 |
CN-212663542-U | Mixing arrangement for intermediate of medicine | 20200611 |
CN-111362891-A | Production device and production method of acetyl tetrahydrofuran | 20200401 |
CN-212152137-U | Production equipment of acetyl tetrahydrofuran | 20200401 |
WO-2021055612-A1 | Substituted imidazole carboxamides and their use in the treatment of medical disorders | 20190917 |
WO-2020063012-A1 | Aminonordecane derivative, and preparation method therefor and application thereof | 20180929 |
WO-2020008183-A1 | Intermediates in the synthesis of c3-substituted cephalosporins | 20180702 |
EP-3818059-A1 | Intermediates in the synthesis of c3-substituted cephalosporins | 20180702 |
EP-3786111-A1 | Method for producing carbon material complex | 20180427 |
US-2021238041-A1 | Method for producing carbon material complex | 20180427 |
PMID | Publication Date | Title | Journal |
11953895 | 20020422 | Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes | British journal of cancer |
Complexity: | 98.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 114.068079557 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 114.068079557 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 26.3Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS